COVID-19 vaccine maker Moderna has petitioned the Food and Drug Administration for full approval of its shots for use for adults 18 and older.

“We are pleased to announce this important step in the U.S. regulatory process for a Biologics License Application (BLA) of our COVID-19 vaccine,” said Moderna CEO Stephane Bancel. “We look forward to working with the FDA and will continue to submit data from our Phase 3 study and complete the rolling submission.”